Node Classification on Pubmed (ASR, CA, Clean Accuracy)
99.85ASRTAGBD (Overwriting)
Evaluation results
| Method | Links | |||
|---|---|---|---|---|
| TAGBD (Overwriting)Defense=Prune2026.03 | 99.85 | 93.1 | 81.61 | |
| TAGBD (Overwriting)Defense=OD2026.03 | 99.85 | 92.75 | 83.69 | |
| TAGBD (Overwriting)Defense=None2026.03 | 99.59 | 93.05 | 81.56 | |
| TAGBD (Appending)Defense=Prune2026.03 | 98.9 | 91.18 | 81.61 | |
| TAGBD (Appending)Defense=None2026.03 | 98.59 | 93.05 | 81.56 | |
| TAGBD (Appending)Defense=OD2026.03 | 97.92 | 94.17 | 83.69 | |
| GTADefense=None2026.03 | 95.76 | 82.22 | 81.56 | |
| DPGBADefense=None2026.03 | 92.55 | 80.26 | 81.56 | |
| UGBADefense=None2026.03 | 92.15 | 83.96 | 81.56 | |
| UGBADefense=Prune2026.03 | 91.84 | 84.71 | 81.61 | |
| DPGBADefense=Prune2026.03 | 89.59 | 80.61 | 81.61 | |
| GTADefense=OD2026.03 | 87.34 | 82.49 | 83.69 | |
| SBA-GenDefense=None2026.03 | 30.51 | 85.12 | 81.56 | |
| UGBADefense=OD2026.03 | 30.25 | 83.99 | 83.69 | |
| SBA-GenDefense=OD2026.03 | 29.63 | 83.94 | 83.69 | |
| SBA-SampDefense=None2026.03 | 28.83 | 83.41 | 81.56 | |
| GTADefense=Prune2026.03 | 26.31 | 82.73 | 81.61 | |
| SBA-SampDefense=Prune2026.03 | 25.17 | 82.56 | 81.61 | |
| SBA-SampDefense=OD2026.03 | 23.57 | 82.74 | 83.69 | |
| SBA-GenDefense=Prune2026.03 | 22.73 | 84.62 | 81.61 | |
| DPGBADefense=OD2026.03 | 18.84 | 82.83 | 83.69 |